ERS 2022: Video met Dr. Wouter van Geffen, MCL Leeuwarden
September 2022
pneumonia
EGFR-TKI
NSCLC
Longkanker
Lung Cancer
ERS 2022
thoracic oncology
Van Geffen
OA2266: Diagnosing non-small cell lung cancer by exhaled-breath profiling using an electronic nose: a multicentre validation study.
Sessie: Lung cancer: from screening to early diagnosis
PA1930: Best first-line therapy for patients with advanced non-small cell lung cancer, performance status 2 without a targetable mutation.
Sessie: Promising new approaches in idiopathic interstitial pneumonias.
NVALT-17: RCT of first-line TKI versus intercalated TKI with chemotherapy for EGFR mutated NSCLC
OA2261:
Wilt u meer lezen? Log dan in.
Gerelateerde items
